Anonymous ID: 89cfa7 March 11, 2022, 11:01 a.m. No.15840647   🗄️.is 🔗kun   >>0693 >>0743 >>0858 >>0944 >>0984 >>1155 >>1286 >>1302 >>1328

first doc translation

 

Translation from Ukrainian

 

STATE INSTITUTION "PUBLIC HEALTH CENTER OF THE MINISTRY OF HEALTH OF UKRAINE"

 

08/19/2021

 

To all interested persons

The State Institution “Public Health Center of the Ministry of Health of Ukraine” (hereinafter referred to as the Center) expresses its respect to you and informs you that from August 30 to September 12, 2021, specialists from the Bernhard Nocht Institute of Tropical Medicine are expected to visit Ukraine

(Hamburg, Germany): Dr. Petra Emmerich Palosh and laboratory specialist Ronald von Possel in the framework of cooperation to improve the epidemiological surveillance of especially dangerous viral infections, namely Dengue, Chikungunya, West Nile, Uzutu and others.

The specialists of our institution during 2016 - 2021 cooperated with the above institute. The planned activities will make it possible to update the most significant issues regarding epidemiological surveillance, as well as problems associated with the registration and accounting of infectious diseases caused by pathogens of especially dangerous viral infections, and will help to improve the awareness of domestic specialists about modern methods of laboratory diagnosis of especially dangerous viral pathogens. During the visit, it is planned to hold a workshop on September 09, 2021 on the basis of the Oleksandrivska Clinical Hospital in Kyiv, where doctors who work with these categories of patients are invited. Also during a visit to the regional Control Centers

and disease prevention in Kharkov, Odessa and Lvov, meetings will be held with epidemiologists and heads of virological laboratories of the noted institutions.

Anonymous ID: 89cfa7 March 11, 2022, 11:06 a.m. No.15840693   🗄️.is 🔗kun   >>0698 >>0743 >>0858 >>0944 >>0970 >>0984 >>1155 >>1286 >>1302 >>1328

>>15840647

 

Memorandum of Understanding

Bernhard Nocht Institute of Tropical Medicine (hereinafter referred to as the Institute)

 

which represents

Egbert Tanich, Chairman of the Board of Directors

Bernhard Nocht Street 74

20359 Hamburg, Germany

 

Contractor

 

Principal Investigator:

 

Dr. Petra Emeric-Paloch

Bernhard Nocht Institute of Tropical Medicine

Department of Virology and Laboratory BSL-4

Bernhard Nocht Street 74

20359 Hamburg, Germany

Tel ++ 49 40 428 18 470

Mob tel ++ 1724552847

Email: emmerich@bni-hamburg.de

 

and

State Institution “Public Health Center of the Ministry of Health of Ukraine” (hereinafter referred to as the Center for Public Health)

 

which represents

 

General Director: Dr. Volodymyr Kurpita, Candidate of Medical Sciences

04071 Kyiv, 41 str. Yaroslavskaya

Ukraine

 

Laboratory research:

 

Dr. Iryna Demchyshyna

Head of the virology laboratory

State Institution "Public Health Center of the Ministry of Health of Ukraine"

04071 Kyiv, street Yaroslavskaya, 41, Ukraine

Tel / fax: + +38 044 425 02 09

Mobile: + +38 050 732 52 32

e-mail: irad@i.ua

 

agree to cooperate in the framework of a joint research project: Improving biosafety and biosecurity by improving the diagnosis and study of the prevalence of Crimean-Congo hemorrhagic fever (CCGG) and Hantavirus in Ukraine 2018-2019, funded by the German Ministry of Foreign Affairs (project 76768 EN 68727 )

Anonymous ID: 89cfa7 March 11, 2022, 11:07 a.m. No.15840698   🗄️.is 🔗kun   >>0743 >>0858 >>0944 >>0970 >>0984 >>1155 >>1286 >>1302 >>1328

>>15840693

cont

 

on the following terms:

 

The aim of the study:

 

Crimea-Congo Hemorrhagic Fever (CHD) is an acute fever characterized by bleeding and functional insufficiency of organs and can cause serious outbreaks in humans. The causative agent of CCGG is the Crimean-Congo virus, which is transmitted by ticks. We will compile documentation on the prevalence of CCG in different regions of Ukraine.

The aim of this study is to improve the process of diagnosing CKD virus in order to improve biosafety and biosecurity.

In addition, diagnostics and appropriate surveillance should be improved, as well as biosafety and biosecurity measures by setting standards and training laboratory staff for Hantaan virus risk group 3. The subtype Hantaan, Puumala and / or the Dobrava-Belgrade virus is transmitted by rodents and can cause severe kidney or respiratory damage depending on the subtype and, in some cases, death.

 

Project duration: January 1, 2018 - December 31, 2019

 

B Memorandum

According to which, the Bernhard Nocht Institute of Tropical Medicine

and the Public Institution Public Health Center of the Ministry of Health of Ukraine undertake to cooperate on Ukrainian health care programs within the framework of the funded project to strengthen relations between the parties and increase laboratory capacity and relevant skills.

 

The CGC will be responsible for providing 1,000 serum samples from different regions of Ukraine. Testing of these samples will be conducted in Ukraine after the completion of the training process, which should be carried out partly by the Ukrainian side and partly at the Bernhard Nocht Institute of Tropical Medicine.

 

  1. The Administration of the Institute will create an official account for project payments and will be responsible for the distribution of funds specified in the project application. All payments must be supported by documentary evidence, which must be provided annually to the Institute and the donor upon request.

 

  1. The Institute will be responsible for paying all costs related to the training of CGD staff at the Bernhard Nocht Institute of Tropical Medicine. The institute also provides the necessary equipment and tools provided by the project.

 

Signed for and by the Public Institution “Public Health Center of the Ministry of Health of Ukraine” (CEH) by the Director General Dr. Volodymyr Kurpita

 

Name

Witness

Signature

 

 

Name

 

Dr. Vladimir Kurpita

 

Date

 

Kyiv, July 2018

 

Signed for and by the Bernhard Nocht Institute of Tropical Medicine

 

Name

Witness

Signature

 

 

Name

 

Prof. Dr. Jürgen May

 

Date

 

Hamburg, July 18, 2018

Anonymous ID: 89cfa7 March 11, 2022, 11:38 a.m. No.15840970   🗄️.is 🔗kun   >>0976 >>0984 >>1018 >>1055 >>1155 >>1286 >>1302 >>1328

>>15840693

>>15840698

next doc

 

Translation from Ukrainian

Memorandum of understanding

Bernhard Nocht Institute for Tropical Medicine (hereinafter Institute)

 

which represents

Egbert Tanich, Chairman of the Board of Directors

Bernhard Nocht Street 74

20359 Hamburg, Germany

 

Contractor

 

Principal Investigator:

 

Dr. Petra Emerich-Paloch

Bernhard Nocht Institute for Tropical Medicine

Department of Virology and Laboratory BSL - 4

Bernhard Nocht Street 74

20359 Hamburg, Germany

Tel +49 40 428 18 470

Mobile phone +1724552847

Email: emmerich@bni-hamburg.de

 

And

State Institution "Public Health Center of the Ministry of Health of Ukraine" (hereinafter PHC)

 

which represents

 

General Director: Dr. Vladimir Kurpita, PhD

04071 Kyiv, 41 st. Yaroslavskaya

Ukraine

 

Laboratory research:

 

Dr. Irina Demchishina

Head of the Laboratory of Virology

State Institution "Public Health Center of the Ministry of Health of Ukraine"

04071 Kyiv, st. Yaroslavskaya, 41, Ukraine

Tel / Fax: +38 044 425 02 09

Mobil: + 38 050 732 52 32

e-mail: irad@i.ua

 

agree to cooperate within the framework of a common research project: Improving the level of biosafety and biosecurity by improving the diagnosis and research on the prevalence of Crimean-Congo hemorrhagic fever (CCHF) and Hantaviruses in Ukraine in 2018-2019, which is funded by the German Ministry of Foreign Affairs (Project No. 68727 EN 02761868)

 

under the following conditions:

 

Purpose of the study :

 

Crimean-Congo hemorrhagic fever (CCHF) is an acute fever characterized by bleeding and organ failure and can cause severe outbreaks in humans. The causative agent of CCHF is the Crimean-Congo virus, which is transmitted by ticks. We will collect documentation on the prevalence of CCHF in different regions of Ukraine.

The purpose of this study is to improve the process of diagnosing the CCHF virus in order to improve biosafety and biosecurity.

In addition, diagnostics and related surveillance should be improved, as well as biosafety and biosecurity activities should be improved by setting standards and training laboratory personnel for handling Hanta virus at risk group 3. The subtype Hantaan, Puumala and/or Dobrava-Belgrade virus is transmitted by rodents and can cause severe damage to the kidneys or respiratory tract depending on the subtype and, in some cases, death.

 

Project duration: January 1, 2018 - December 31, 2019

 

B Memorandum

According to which the Bernhard Nocht Institute of Tropical Medicine and the State Institution "Center for Public Health of the Ministry of Health of Ukraine" undertake to cooperate on Ukrainian health programs within the funded project, to strengthen relations between the parties and build laboratory capacity and related skills.

 

The PHC will be responsible for providing 1,000 serum samples from different regions of Ukraine. Testing of these samples will be carried out in Ukraine upon completion of the training process, which should be carried out partly by the Ukrainian side and partly at the Bernhard Nocht Institute for Tropical Medicine.

 

  1. The administration of the Institute will create an official account for disbursements to the project and will be responsible for distributing the funds identified in the project application. All payments must be supported by documentary evidence, which must be provided annually to the Institute and the donor upon request.

 

  1. The institute will be responsible for paying all costs associated with the training of PHC staff at the Bernhard Nocht Institute for Tropical Medicine. The Institute also provides the necessary equipment and tools foreseen by the project.

 

Signed for and by the State Institution "Public Health Center of the Ministry of Health of Ukraine" (PHC) by the Director General Dr. Volodymyr Kurpyta

Anonymous ID: 89cfa7 March 11, 2022, 11:50 a.m. No.15841055   🗄️.is 🔗kun   >>1090 >>1155 >>1286 >>1302 >>1328

>>15840970

next

 

Threat Reduction Agency,

Biological Threat Reduction Program

International project manager in Ukraine

P. Brand Siegel

 

Copy: US Embassy in Ukraine,

DTRO-K

 

Dear Mr. Siegel Brand!

 

We take this opportunity to express our deep respect to you and the US Department of Defense Threat Reduction Agency for many years of fruitful cooperation and support of Ukrainian veterinary science.

In response to your letter DTRO 21-016 dated January 26, 2021, the NAAS Department of Veterinary Medicine (National Research Center "Institute of Experimental and Clinical Veterinary Medicine" and the NAAS Institute of Veterinary Medicine) prepared short descriptions of five project proposals focusing on study of particularly dangerous microorganisms:

1. Improvement of possibilities for regional cooperation and capacity building for emerging ruminant diseases (foot-and-mouth disease, bluetongue, lumpy skin disease and sheep and goat pox) surveillance system in the Eurasian nosoareal.

2. Regional monitoring of emerging poultry diseases (influenza, Newcastle disease) in migrating wild birds in the Eurasian migration corridor, and characteristics of circulating pathogens.

3. Risk assessment and zoonotic threats identification in reptiles as a reservoir of zoonotic pathogens using NGS (full genome sequencing).

4. Study of the African swine fever natural foci formation in Ukraine.

5. Study of reemergence risks of Anthrax in Ukraine.

We send you these proposals (Appendix - 5 pages). They will also be emailed to Dr. Megan Howard.

 

Sincerely,

Academician-Secretary

Department of Veterinary Medicine NAAS,

Corresponding Member of NAAS MS Mandigra

Anonymous ID: 89cfa7 March 11, 2022, 11:57 a.m. No.15841090   🗄️.is 🔗kun   >>1135 >>1155 >>1176 >>1286 >>1302 >>1328

>>15841055

next

 

Translation of fragments of the clinical protocol from Ukrainian

 

Clinical protocol

 

Title: Prospective assessment of morbidity and differential diagnosis of Crimean-Congo hemorrhagic fever and hantavirus infections in patients hospitalized with suspected leptospinosis and febrile illness of unknown etiology in Ukraine.

 

Protocol number: To be determined later

 

Principal Investigator: Gainutdinova Tatyana Ildarovna

Head of the Infectious Diseases Department No. 1 of the Oleksandrivska Clinical Hospital in Kyiv

Tel.: +38 (044) 379-23-60

E-mail: gainut2106@gmail.com

 

Leading researcher (Lvov): Elena Zubach, Candidate of Medical Sciences, infectious disease specialist, Lviv National Medical University named after Danylo Halytsky

Tel.: +38 (0322) 36-83-52

E-mail: dr_zubach@i.ua

 

Speaker (Lviv): Orfin Andrey Yaroslavovich, infectious disease specialist, Lviv Regional Clinical Hospital

Tel.: +38 (0322) 75-54-05

E-mail: aorf87@gmail.com

 

Lead Speaker (USA): Gregory Merz, Professor Emeritus of Internal Medicine, University of New Mexico

Albuquerque, New Mexico 87131-0001, USA

Tel.: +1 (505) 980-8601

E-mail: gmertz@salud.unm.edu

 

Speakers (USA): Colin Johnson (Women), Ph.D.

Leading Researcher, Department of Virology, Microbiology, Immunology

Director of the Regional Biosafety Laboratory

858 Madison Avenue Lab 811

Memphis, Tennessee 38613, USA

Tel.: +1(901) 456-98-66

E-mail: cjonsson@uthsc.edu

 

Gregory Glass, PhD

Professor, University of Florida, Emerging Pathogens Institute

2055 Mowry Road, Gainesville, FL 32610 USA

Tel.: +1 (410) 236-10-66

E-mail: gglass@ufl.edu

 

 

4.0 Clinical/medical monitoring

 

The following U.S.-based groups can view data on all study subjects included in this protocol, as well as flag instances of non-compliance with this protocol: U.S. Department of Defense, UNMHSC Study Subject Protection, and UTHSC Bioethics Committees. The Bioethics Committee of Ukraine may also review records to ensure they comply with Ukrainian regulatory standards. In addition, any data obtained from this study should be available for verification upon request of the Ukrainian Committee of Bioethics and representatives of the US Department of Defense. One member of the study team will monitor the quality of the study and apply measures to ensure it is of the required level.

Anonymous ID: 89cfa7 March 11, 2022, 12:03 p.m. No.15841135   🗄️.is 🔗kun   >>1176

>>15841090

>Lead Speaker (USA): Gregory Merz,

 

Mertz, Gregory Professor

Positions

 

Faculty, Center for Global Health

Visiting Professor, Division of Infectious Diseases , Department of Internal Medicine

 

Dr.Mertz is Professor Emeritus of Internal Medicine and Former Chief of the Division of Infectious Diseases. He received his MD degree from Rush Medical College and completed residency training in Internal Medicine and fellowship training in Infectious Diseases from the University of Washington in Seattle. He is board certified in Internal Medicine and Infectious Diseases. His clinical and research interests include hantavirus and herpesvirus infections, HIV/AIDS and general infectious diseases. Since 1999,Dr. Mertz has been the principal investigator of a NIH/NIAID-sponsored=research grant, which is focused on hantavirusinfections in central and southern Chile. (less)

Anonymous ID: 89cfa7 March 11, 2022, 12:10 p.m. No.15841176   🗄️.is 🔗kun   >>1264 >>1286 >>1302 >>1328

>>15841090

>>15841135

next

 

Translation from Ukrainian

 

STATE INSTITUTION

"PUBLIC HEALTH CENTER

OF THE MINISTRY OF HEALTH OF UKRAINE"

 

Head of the Kiev City Department of the State Tax Service

Rodina R.A.

04071, Kyiv, st. Yaroslavskaya, 41

 

STATEMENT

State Institution "Public Health Center of the Ministry of Health of Ukraine" 40524109

 

declares a declaration about items whose tax value is less than the equivalent of 100 euros / 200 euros /, as well as other information necessary for tax control and tax clearance of these items without applying a cargo tax declaration /tax declaration M16/.

Transport document number

Invoice/Invoice

Destination Australia

Recipient Victorian Reference Laboratory for Infectious Diseases - Dougherty Institute.

Number of items

Total weight (kg)

Total tax value 10 USD

 

Name of the object, its distinguishing features

Product code according to UKTZED

The cost of goods in national or foreign currency

Samples of materials - human blood serum- 350 cryovessels

 

10 USD

 

invoice

 

Export date 12/11/2018

Special marks

EXPORTER

RECIPIENT

Phone 380444250209

Demchishina Irina

State Institution "Center for Public Health of the Ministry of Health"

Yaroslavskaya st. 41, Kyiv, Ukraine

Phone +61393429646

Vicky Stumbos/Swellen Nicholson

792 Elizabeth Street

Melbourne, Victoria

Australia

Country of export UA

Importer - if different from recipient

Country of origin UA

 

Country of destination AUSTRALIA

 

Number of packages

Type of packaging

Full description of the property

Qty

Weight

Unit cost

total cost

 

Human serum

one

2 kg

$10

$10

Total number of packages

 

total weight

 

1 (one)

 

2 kg

 

$10

 

I hereby certify that all of the items listed are non-corrosive, non-oxidizing, non-magnetic, non-toxic and non-hazardous and can be transported on any commercial aircraft.

I declare that all information contained in the consignment note is true.

Exporter's signature:

Anonymous ID: 89cfa7 March 11, 2022, 12:23 p.m. No.15841264   🗄️.is 🔗kun   >>1286 >>1296 >>1302 >>1328

>>15841176

one moar

 

September 11, 2020

Transfer Agreement

 

Provider: National Scientific Center Institute of Experimental and Clinical Veterinary Medicine, Dr. Denys V. Muzyka, Head of Avian Diseases Department, Pushkinska St. 83, Kharkiv, Ukraine, 61023 dmuzyka77@gmail.com Office: +38-057-707-20-18 Fax: +38-057-704-10-90

Recipient: Friedrich-Loeffler-Institut, Suedufer 10, 17493 Greifswald-Insel Riems, Germany recipient scientist: Prof. Dr. Cornelia Silaghi, Cornelia.Silaghi@fli.de Head of the Institute of Infectology (IMED).

 

Together or individually referred to as “Parties” or “Party”

We have agreed that, the Provider, will transfer to the Recipient samples of ectoparasites of bat. The samples were obtained in Ukraine in frame of collaboration of National Scientific Center “Institute of Experimental and Clinical Veterinary Medicine” (Kharkiv, Ukraine) and Bat Rehabilitation Center (Kharkiv, Ukraine) in 2020.

 

Besides the Provider will transfer to Recipient 147 samples of ectoparasites (in tubes 0.2 ml with 70 % ethanol):

List of samples of fleas.

 

Sample ID

Bat species

Parasite species

FLEAS

UKR 001 NNOC N. CF. Eusarc

Nyctalus noctula

Nycteridopsylla cf. Eusarca

UKR 002 NNOC N. CF. Eusarc

Nyctalus noctula

Nycteridopsylla cf. Eusarca

UKR 003 NNOC N. CF. Eusarc

Nyctalus noctula

Nycteridopsylla cf. Eusarca

 

This material is uninfectious and does not present a danger for humans and animals.

 

This Material will be used by Recipient solely for detection of following pathogens: rickettsia, Bartonella, Anaplasma, viruses, protozoa???…………………. and for sequencing genome……????. This Material will not be used for commercial purposes, such as production or sale of products or services, for which a commercialization license may be required. Recipient will promptly inform Provider of the results of the study. This Material is considered proprietary to Provider. Recipient therefore agrees to retain control over this Material, and further agrees not to transfer the Material to other people not under its supervision without prior written approval of Provider. Provider reserves the right to distribute the Material to others and to use it for its own purposes. This Material is being supplied to recipient with no warranties, expressed or implied, including any warranty of merchantability or fitness for a particular purpose. Nothing in this Transfer shall or may be construed as granting Recipient any right or license to the Material for any use other or further than the evaluation described here above.

The sequencing results shall be owned by the Recipient. The Parties agree to give each other a right to use the Material and the Research Results for research and education purposes without the prior written consent of the other Party. Any further use of the Material and the Research Results not covered by this Agreement, such as transfer to third parties and the above-mentioned commercial purposes, shall only be allowed upon agreement by the Parties.

 

Signature:

Provider:

Director of the NSC IECVM,

Dr. Sc (Vet. Med.), NAAS Academician Prof. Borys Stegniy

 

Head of Avian Diseases Department Dr. Denys Muzyka

 

Head of Bat Rehabilitation Center Dr. Anton Vlaschenko, 

 

 

 

Recipient:

 

Friedrich-Loeffler-Institut, Prof. Dr. Dr. Thomas C. Mettenleiter